Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease
January 03, 2017 07:43 ET | Abeona Therapeutics Inc.
NEW YORK, NY and CLEVELAND, OH --(Marketwired - January 03, 2017) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics to Present at 2016 Genetic Rx Boston Biotech Conference at Harvard Medical School
December 06, 2016 07:43 ET | Abeona Therapeutics Inc.
NEW YORK, NY and CLEVELAND, OH--(Marketwired - December 06, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics to Present at World Orphan and Drug Congress Europe 2016
November 15, 2016 07:58 ET | Abeona Therapeutics Inc.
NEW YORK, NY and CLEVELAND, OH--(Marketwired - November 15, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO) a clinical-stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics Announces Third Quarter 2016 Financial Results and Recent Clinical Highlights
November 10, 2016 07:43 ET | Abeona Therapeutics Inc.
NEW YORK, NY and CLEVELAND, OH--(Marketwired - November 10, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO) a clinical-stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics Honored with Partner in Progress Award from DEBRA of America
November 05, 2016 14:03 ET | Abeona Therapeutics Inc.
NEW YORK, NY and CLEVELAND, OH--(Marketwired - November 05, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics to Present at Alliance of Regenerative Medicine 4th Annual Advanced Therapies Investor Day in London, UK
November 03, 2016 07:43 ET | Abeona Therapeutics Inc.
NEW YORK, NY and CLEVELAND, OH--(Marketwired - November 03, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics Announces JAMA Publication of Positive Phase 1 Study Results for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa
November 02, 2016 08:03 ET | Abeona Therapeutics Inc.
NEW YORK, NY and CLEVELAND, OH--(Marketwired - November 02, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO): EB-101 Phase 1 clinical trial therapy demonstrated clinical efficacy of 67% healed wounds...
Abeona Therapeutics Inc. Announces Closing of its Underwritten Offering of Common Stock
November 01, 2016 10:23 ET | Abeona Therapeutics Inc.
NEW YORK, NY, and CLEVELAND, OH--(Marketwired - November 01, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics Announces Pricing of Public Offering of Common Stock
October 27, 2016 09:12 ET | Abeona Therapeutics Inc.
NEW YORK, NY, and CLEVELAND, OH--(Marketwired - October 27, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical stage biopharmaceutical company focused on developing therapies for...
Abeona Therapeutics Announces Public Offering of Common Stock
October 26, 2016 16:14 ET | Abeona Therapeutics Inc.
NEW YORK, NY, and CLEVELAND, OH--(Marketwired - October 26, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical stage biopharmaceutical company focused on developing therapies for...